Table 1.

Clinical characteristics of IgAN patients

				P-value
	Group 1 (n = 49)	Group 2 (n = 63)	Group 3 (n = 50)	1 versus 2	1 versus 3	2 versus 3
Mean age (years)	33·51 ± 11·07	36·41 ± 11·91	35·98 ± 12·59	0·461	0·661	0·997
Male/female	26/23	25/28	31/19	0·552	0·368	0·131
Hypertension	9/49	13/63	35/50	0·764	<0·001	<0·001
SCr (µmol/l)	66·69 ± 18·16	88·60 ± 46·65	253·34 ± 197·57	0·003	<0·001	<0·001
eGFR (ml/min/1·73 m2)	121·42 ± 26·42	93·78 ± 34·59	42·45 ± 31·11	<0·001	<0·001	<0·001
Proteinuria (g/24 h)	1·71 ± 2·38	1·93 ± 2·04	4·14 ± 3·11	0·938	<0·001	<0·001
Loss to follow-up	3/49	6/63	8/50	0·511	0·118	0·299
Remission	39/46	39/57	7/42	0·054	<0·001	<0·001

IgAN: immunoglobulin A nephropathy; SCr: serum creatinine; eGFR: estimated glomerular filtration rate.